Add to ORKGExenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority stud
AIMS: The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide once weekly (ExQW) and lir...
BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care ...
Elaine Chiquette,1 Peter P Toth,2 Gilbert Ramirez,3 Michael Cobble,4 Robert Chilton51Amylin Pharmace...
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, paral...
Katherine V Mann,1 Philip Raskin2 1PharmD Consulting, LLC, Royal Oak, MD, USA; 2Department of Intern...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
Jason Seewoodhary1, Leanne Griffin1, Stephen C Bain11Department of Diabetes and Endocrinology, Swans...
Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treat...
Class of 2013 AbstractSpecific Aims: To determine the effectiveness of exenatide twice daily (ExBID)...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a hre...
To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), piogli...
Aims/Introduction To compare safety and efficacy of the extended-release formulation exenatide once ...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
In this study, we retrospectively compared the effectiveness of exenatide once-weekly (ExeOW) versus...
AIMS: The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide once weekly (ExQW) and lir...
BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care ...
Elaine Chiquette,1 Peter P Toth,2 Gilbert Ramirez,3 Michael Cobble,4 Robert Chilton51Amylin Pharmace...
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, paral...
Katherine V Mann,1 Philip Raskin2 1PharmD Consulting, LLC, Royal Oak, MD, USA; 2Department of Intern...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
Jason Seewoodhary1, Leanne Griffin1, Stephen C Bain11Department of Diabetes and Endocrinology, Swans...
Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treat...
Class of 2013 AbstractSpecific Aims: To determine the effectiveness of exenatide twice daily (ExBID)...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a hre...
To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), piogli...
Aims/Introduction To compare safety and efficacy of the extended-release formulation exenatide once ...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
In this study, we retrospectively compared the effectiveness of exenatide once-weekly (ExeOW) versus...
AIMS: The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide once weekly (ExQW) and lir...
BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care ...
Elaine Chiquette,1 Peter P Toth,2 Gilbert Ramirez,3 Michael Cobble,4 Robert Chilton51Amylin Pharmace...